Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety Trial of the ALK HDM Tablet in House Dust Mite Allergic Subjects
This study has been completed.
Study NCT00389363   Information provided by ALK-Abelló A/S

First Received on October 17, 2006.   Last Updated on August 16, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Asthma
More general conditions related to this trial
Bronchial Diseases
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Lung Diseases
Lung Diseases, Obstructive
Respiratory Hypersensitivity
Respiratory Tract Diseases
Interventions listed in this trial
ALK HDM tablet
Sponsors listed in this trial
ALK-Abelló A/S


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services